Administration of a 'Thirst Relieve Kit' Versus Placebo in Patients After Hospital-based Bowel Pr… (NCT07699809) | Clinical Trial Compass
RecruitingNot Applicable
Administration of a 'Thirst Relieve Kit' Versus Placebo in Patients After Hospital-based Bowel Preparation for Colonoscopy and Assessment of Thirst Intensity
Brazil158 participantsStarted 2025-12-08
Plain-language summary
The goal of this study is to evaluate whether a "thirst kit" (lemon popsicle) is effective in reducing thirst intensity in patients undergoing hospital bowel preparation for colonoscopy. The study also aims to assess the impact of the thirst kit on associated symptoms and patient satisfaction. The main questions it aims to answer are:
* Does the thirst kit reduce the intensity of thirst after bowel preparation for colonoscopy?
* Does the thirst kit reduce symptoms such as dry mouth and dry throat?
* How satisfied are patients when using the thirst kit compared to a placebo?
Researchers will compare the thirst kit to a placebo to determine its effectiveness in managing thirst during the pre-colonoscopy period.
Participants will:
* Be randomly assigned to receive either the thirst kit (lemon popsicle) or a placebo
* Use the assigned intervention during the hospital preparation period for colonoscopy
* Rate thirst intensity, associated symptoms, and satisfaction using numerical scales
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* both sexes
* aged 18 years or older, with clear awareness and good cooperation
* who underwent colonoscopy with hospital bowel preparation
Exclusion Criteria:
* any risk of oral fluid aspiration
* swallowing disorders
* post-operative advanced head and neck surgeries
* advanced head and neck neoplasia, active oral diseases (oral mucosal lesions, stomatitis, among others)
* history of gastric surgeries (gastrectomized, upper gastrointestinal tract surgeries for obesity)
* use of GLP-1 analog medications and derivatives in the last 10 days according to hospital protocol (e.g., semaglutide, liraglutide, dulaglutide, tirzepatide...)
* history of dementia.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The primary outcome of the study is the intensity of thirst, assessed using a numerical scale (0-10) after administration of the thirst kit or placebo.
Timeframe: 10 minutes before the sedation for the exam starts (when the patient arrives in the examination room)